日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacology of bisphosphonates

双膦酸盐的药理学

Cremers, Serge; Drake, Matthew T; Ebetino, F Hal; Bilezikian, John P; Russell, R Graham G

Zoledronate Attenuates Accumulation of DNA Damage in Mesenchymal Stem Cells and Protects Their Function

唑来膦酸可减轻间充质干细胞中 DNA 损伤的积累并保护其功能

Juhi Misra, Sindhu T Mohanty, Sanjeev Madan, James A Fernandes, F Hal Ebetino, R Graham G Russell, Ilaria Bellantuono

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis

双膦酸盐长期治疗及其在绝经后骨质疏松症中的安全性

Pazianas, Michael; Cooper, Cyrus; Ebetino, F Hal; Russell, R Graham G

A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites

一种治疗肿瘤诱发骨病的有前景的方法:利用核苷抗代谢物的双膦酸盐衍生物

Reinholz, Monica M; Zinnen, Shawn P; Dueck, Amylou C; Dingli, David; Reinholz, Gregory G; Jonart, Leslie A; Kitzmann, Kathleen A; Bruzek, Amy K; Negron, Vivian; Abdalla, Abdalla K; Arendt, Bonnie K; Croatt, Anthony J; Sanchez-Perez, Luis; Sebesta, David P; Lönnberg, Harri; Yoneda, Toshiyuki; Nath, Karl A; Jelinek, Diane F; Russell, Stephen J; Ingle, James N; Spelsberg, Thomas C; Dixon, Henry B F Hal; Karpeisky, Alexander; Lingle, Wilma L

Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase

阿扑胺通过下调 3-羟基-3-甲基戊二酰辅酶 A 还原酶增强洛伐他汀对骨髓瘤细胞的抗肿瘤作用

Anke J Roelofs, Claire M Edwards, R Graham G Russell, F Hal Ebetino, Michael J Rogers, Philippa A Hulley